Track topics on Twitter Track topics that are important to you
12 Gill Street, Suite 1400
United States of America
The primary high-risk human papillomavirus (hrHPV) assays in the United States are the cobas (Roche) and the Aptima (Hologic). The cobas assay detects hrHPV by DNA analysis while the Aptima detects me...
Timely and precise laboratory diagnosis of Herpes simplex viruses (HSV) is required to guide clinical management.
Quantification of HBV DNA is used for initiating and monitoring antiviral treatment. Analytical test performance consequently impacts treatment decisions.
Human papillomavirus (HPV) tests and genotyping (GT) have been used in clinical risk assessment. The purpose of this study was to analyze the performance of 2 common HPV testing platforms in risk eval...
This study compared performance of Atlas io® diagnostic platform, a point-of-care (POC) PCR assay for Chlamydia trachomatis (CT), to Aptima Combo 2, a standard of care laboratory-based nucleic acid a...
The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. Th...
To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...
This non-interventional clinical study will be conducted to prospectively collect serial plasma samples from subjects with chronic HBV infection who are initiating antiviral therapy. These...
The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.
This non-interventional clinical study will be conducted to prospectively collect serial plasma and serum samples from treatment naïve subjects with chronic HCV infection who are initiati...
Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and trainin...
Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human ...
We have published hundreds of Aptima, Inc. news stories on BioPortfolio along with dozens of Aptima, Inc. Clinical Trials and PubMed Articles about Aptima, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptima, Inc. Companies in our database. You can also find out about relevant Aptima, Inc. Drugs and Medications on this site too.